Finny logo
Dibs:
Dibs:
0

AADR vs BBP

Both AADR and BBP are ETFs. AADR has a higher 5-year return than BBP (11.63% vs 9.84%). AADR has a higher expense ratio than BBP (1.1% vs 0.79%). Below is the comparison between AADR and BBP.

AADR BBP
Security Type ETF ETF
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: U.S. Biotech
Family AdvisorShares Virtus
Net Assets $86.20M $26.30M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.31% 0.00%
Underlying Index -- LifeSci Biotechnology Products Index
YTD Return 8.52% -0.99%
1-Year Return 17.64% 8.53%
3-Year Return 9.48% 6.67%
5-Year Return 11.63% 9.84%
10-Year Return 9.43% 0.00%

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return 8.52%
1-Month Return -1.86%
3-Month Return 1.00%
1-Year Return 17.64%
3-Year Return 9.48%
5-Year Return 11.63%
10-Year Return 9.43%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (45.63% of Total Assets)

Name Symbol % Assets
MercadoLibre Inc MELI.SA 7.21%
NICE Ltd ADR NICE 6.54%
Gold Fields Ltd ADR GFI.JO 5.86%
argenx SE ADR ARGX 5.52%
Anglogold Ashanti Ltd ADR AU.JO 3.64%
TAL Education Group ADR TAL 3.63%
ASML Holding NV ADR ASML 3.59%
ZTO Express (Cayman) Inc ADR ZTO 3.35%
Sibanye Stillwater Ltd ADR SBSW.JO 3.21%
LVMH Moet Hennessy Louis Vuitton SE ADR LVMUY.PA 3.08%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    BBP description

    The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate.

    BBP performance & returns

    YTD Return -0.99%
    1-Month Return 4.16%
    3-Month Return -2.05%
    1-Year Return 8.53%
    3-Year Return 6.67%
    5-Year Return 9.84%
    10-Year Return 0.00%
    BBP expense ratio is 0.79%.

    BBP holdings

    Top 10 Holdings (34.61% of Total Assets)

    Name Symbol % Assets
    Sage Therapeutics Inc SAGE 4.86%
    BeiGene Ltd ADR BGNE 4.34%
    Amicus Therapeutics Inc FOLD 3.91%
    Ultragenyx Pharmaceutical Inc RARE 3.54%
    Blueprint Medicines Corp BPMC 3.51%
    Retrophin Inc RTRX 3.17%
    Halozyme Therapeutics Inc HALO 2.94%
    Insmed Inc INSM 2.90%
    United Therapeutics Corp UTHR 2.79%
    Seagen Inc Ordinary Shares SGEN 2.65%

    Other relevant BBP comparisons

    You may also want to check out the following BBP comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
    Follow Us